Global Cord Blood (CO) Competitors $1.45 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock CO vs. CORBF, MRAI, EMBC, ALT, SBTX, USNA, OMI, PSNL, AVNS, and TNGXShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Global Cord Blood (CORBF), Marpai (MRAI), Embecta (EMBC), Altimmune (ALT), Silverback Therapeutics (SBTX), USANA Health Sciences (USNA), Owens & Minor (OMI), Personalis (PSNL), AVANOS MEDICAL (AVNS), and Tango Therapeutics (TNGX). Global Cord Blood vs. Its Competitors Global Cord Blood Marpai Embecta Altimmune Silverback Therapeutics USANA Health Sciences Owens & Minor Personalis AVANOS MEDICAL Tango Therapeutics Global Cord Blood (NYSE:CORBF) and Global Cord Blood (NYSE:CO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Does the media prefer CORBF or CO? In the previous week, Global Cord Blood had 1 more articles in the media than Global Cord Blood. MarketBeat recorded 2 mentions for Global Cord Blood and 1 mentions for Global Cord Blood. Global Cord Blood's average media sentiment score of 0.56 beat Global Cord Blood's score of 0.00 indicating that Global Cord Blood is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Global Cord Blood 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Global Cord Blood 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation & earnings, CORBF or CO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobal Cord Blood$196.12M0.90$79.04MN/AN/AGlobal Cord Blood$1.24B0.14$79.04M$0.642.27 Is CORBF or CO more profitable? Company Net Margins Return on Equity Return on Assets Global Cord BloodN/A N/A N/A Global Cord Blood N/A N/A N/A Which has more volatility & risk, CORBF or CO? Global Cord Blood has a beta of -0.52, meaning that its stock price is 152% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500. SummaryGlobal Cord Blood beats Global Cord Blood on 3 of the 5 factors compared between the two stocks. Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CO vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$176.25M$124.94M$5.56B$20.70BDividend YieldN/AN/A5.22%3.71%P/E Ratio2.271.1327.6928.10Price / Sales0.140.56423.8038.27Price / Cash4.192.8036.8922.53Price / Book0.230.238.034.58Net Income$79.04M$43.11M$3.18B$985.54M7 Day PerformanceN/A-2.22%2.93%2.79%1 Month PerformanceN/A22.21%1.72%4.37%1 Year Performance31.82%45.57%34.39%15.08% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COGlobal Cord BloodN/A$1.45flatN/AN/A$176.25M$1.24B2.271,202News CoverageCORBFGlobal Cord BloodN/A$1.18-6.3%N/AN/A$143.43M$196.12M0.001,200News CoverageGap DownMRAIMarpaiN/A$1.26-9.4%N/A+73.1%$19.79M$34.87M-0.48150EMBCEmbecta4.147 of 5 stars$9.82+0.5%$19.33+96.9%-9.9%$570.98M$1.12B10.912,100ALTAltimmune2.2322 of 5 stars$6.99-0.6%$19.00+171.8%-28.1%$570.18M$20K-5.5550SBTXSilverback TherapeuticsN/A$15.80-0.7%N/A+81.5%$569.72MN/A-6.5383High Trading VolumeUSNAUSANA Health Sciences3.4369 of 5 stars$30.30-0.8%$36.00+18.8%-25.5%$568.93M$854.50M16.651,700OMIOwens & Minor4.5908 of 5 stars$7.28-0.8%$12.33+69.4%-27.5%$567.05M$10.70B-1.5323,200PSNLPersonalis3.3812 of 5 stars$6.21-3.3%$7.67+23.5%+393.8%$567.05M$84.61M-4.81400News CoverageAVNSAVANOS MEDICALN/A$12.09-0.4%N/A-36.1%$561.40M$687.80M-1.442,227TNGXTango Therapeutics2.0032 of 5 stars$5.32+3.1%$12.20+129.3%-33.5%$559.31M$42.07M-4.3690Analyst Revision Related Companies and Tools Related Companies CORBF Competitors MRAI Competitors EMBC Competitors ALT Competitors SBTX Competitors USNA Competitors OMI Competitors PSNL Competitors AVNS Competitors TNGX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CO) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 4th: 59% dividend from Bitcoin (No Crypto Needed)I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Y...Investors Alley | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
